The research field of glucose biosensing has shown remarkable growth and development
since the first reported enzyme electrode in 1962. Extensive research on various …

Biosensing and diagnostic platforms with high sensitivity, specificity, and fast response time
are based on immobilized biomolecules such as antibodies (Abs), aptamers, enzymes …

This review covers a broad range of well-established and novel diagnostic platforms which
are currently being considered for use in commercial point-of care (POC) diagnostics …

The rapid development of accurate and quick diagnostic tools for infectious diseases has
made a massive impact in global health. POC devices for pathogen detection have primarily …

Personal glucose meters (PGMs) have been used for the measurement of blood glucose for
decades now such that they have become the most used analytical method in the world …

Rapid diagnostics that can accurately inform patients of disease risk and protection are
critical to mitigating the spread of the current COVID-19 pandemic and future infectious …

There is a critical need for point-of-care (POC) diagnostics in health care and a parallel need
for similar point-of-need (PON) diagnostics in other sectors. Such technology could have a …

Recent advances in mobile network and smartphones have provided an enormous
opportunity for transforming in vitro diagnostics (IVD) from central labs to home or other …

A blood glucose meter is an electronic medical device used for determining the
concentration of glucose in blood. These meters have undergone five phases of …

There is a growing demand for high-performance point-of-care (POC) diagnostic
technologies where in vitro diagnostics (IVD) is essential for prevention, identification, and …